NEW YORK (GenomeWeb News) — Pressure BioSciences today said it has received $1.8 million for selling its Source Scientific subsidiary to two individuals, Richard Henson and Bruce Sargeant.
 
PBI had originally received $1.2 million, which comprised a repayment of aggregate principal and promissory notes stemming from a 2004 agreement under which Sargeant and Henson bought 70 percent of Source Scientific.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.